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Many inborn errors of metabolism are characterized by an increase in the 
concentrations of various carboxylic acids in blood and urine. For example, 
the metabolic disorders propionic acidemia [ 11, methylmalonic aciduria [ 2,3], 
maple syrup urine disease [4], isovaleric acidemia [ 41 and glutaric aciduria 
type II [ 5,6] show increased amounts of volatile carboxylic acids in blood or 
urine. Procedures for the profiling and/or quantitation of these carboxylic acids 
require their isolation from blood or urine by vacuum distillation [6], 
extraction [ 7,8] , silicic acid absorption [ 91 or ion-exchange chromatography 
[lo] prior to gas chromatographic (GC) or gas chromatographic-mass 
spectrometric (GC-MS) analysis. These procedures are time-consuming and 
may result in losses of the more volatile acids. We have developed a rapid proce- 
dure for the profiling of volatile carboxylic acids in blood and urine that 




All reference carboxylic acids were purchased either from Sigma (St. Louis, 
MO, U.S.A.) or Aldrich (Milwaukee, WI, U.S.A.) either as the free acid or 
as the sodium salt and were used as received. The 10% SP-1200--l% H3P04 
on 80-100 Chromosorb W AW (1.83 m X 2 mm I.D.) and the 10% 
SP-1000-l% H3P04 on 100-200 Chromosorb W AW (1.83 m X 2 mm I.D.) 
glass GC columns were purchased from Supelco (Bellefonte, PA, USA.). 
A Varian 3700 gas chromatograph (Palo Alto, CA, U.S.A.) with a flame ioniza- 
tion detector was used for the volatile carboxylic acid profiling. The profiles 
were recorded on a Varian 9176 recorder. 
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Analytical procedure 
GC columns were conditioned at 190°C with a nitrogen flow-rate of 
30 ml/min. Periodic injection of a 1% formic acid solution was performed 
until a stable baseline resulted (l-2 days). 
Urine profiling. To 1.00 ml of urine were added 10 ~1 of a 0.05 mmol/ml 
trimethylacetic acid (internal standard) [ 91 solution. The sample was acidified 
by the addition of 3-5 drops of 1 M hydrochloric acid. A 2-~1 aliquot was 
injected onto the SP=1200 column. Column temperature, 90°C for 4 min then 
5”/min to 200°C; injector temperature, 230°C; detector temperature, 230°C; 
nitrogen flow-rate, 30 ml/mm 
Urine samples exhibiting an abnormal profile were analyzed on the SP-1000 
column. A l-cl1 aliquot of the sample was injected onto the SP-1000 column. 
Column temperature, 150°C; injector temperature, 230°C; detector 
temperature, 230°C; nitrogen flow-rate, 30 ml/mm 
Peak identification was by the peak relative retention time (RRT) on each 
column and peak enhancement when the urine sample was spiked with the 
authentic reference compound. 
Between sample injections, 10 ~1 of a 1% formic acid solution were injected 
onto the column to remove ghost peaks. 
RESULTS AND DISCUSSION 
Blood or urine samples are profiled initially on an SP-1200 column [ll] 
using a temperature gradient. Volatile carboxylic acids that can be separated 
in this manner are shown in Fig. 1A. Table I lists the retention time and the 
RRT (relative to the internal standard) of each carboxylic acid. Butanoic acid 
appears as a shoulder on the internal standard peak (RRT slightly greater than 
1.0) while 2-methylbutanoic and 3-methylbutanoic acids are not separated. 
In Fig. 1B is shown the profile of an abnormal urine sample (due to valproic 
acid therapy) on the SP-1200 column. At this sensitivity, the profile of a 
normal sample would show only the internal standard peak. Abnormal samples 
detected by the fist method are then analyzed isothermally (150°C) on an 
SP-1000 GC column [ll] which permits resolution of a greater number of 
volatile carboxylic acids than can be separated under the previous conditions. 
These separations are shown in Fig. 2. In Table II are listed the retention time 
and RRT (relative to the internal standard) of each carboxylic acid on the 
SP-1000 column. 
Fig. 3A shows the urinary volatile carboxylic acid profile from an infant 
with methylmalonic aciduria and Fig. 3B shows the plasma volatile carboxylic 
acid profile from the same infant. Under the GC conditions of the profiling 
procedure, methylmalonic acid quantitatively undergoes a thermal 
decarboxylation to propanoic acid [ 121. Confirmation that the large propanoic 
acid peak in these profiles was due to methylmalonic acid and not propanoic 
acid was provided by a positive (purple) reaction of the urine and plasma 
samples with tetrazotized o-dianisidine (Fast Blue B) [ 13 1. Methylmalonic acid 
reacts with tetrazotized o-dianisidine while propanoic acid does not react. 
Without access to a gas chromatograph-mass spectrometer we are not able 
to confirm the identity of each peak in the chromatogram. Thermally labile 
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Fig. 1. A, Profile of the standard volatile carboxylic acid mixture on the SP-1200 column 
using a temperature program: 90°C for 4 min then 5”Clmin to 200°C. Peaks: 1 = propanoic 
acid; 2 = isobutyric acid; 3 = internal standard, trimethylacetic acid; 4 = 2-methylbutanoic 
and 3-methylbutanoic acids; 5 = crotonic acid; 6 = pentanoie acid; 7 = fl-methylcrotonic 
acid; 8 = tiglic acid; 9 = isocaproic acid; 10 = hexanoic acid. The concentration of each acid 
was 3 nmol/ml. B, Profile of an abnormal urine sample on the SP-1200 column (temperature 
program: 90°C for 4 min then S”C/min to 200°C). Peaks: 1 = 3-heptanone (from vaiproic 
acid); 2 = internal standard, trimethylacetic acid; 3 = pentanoic acid; 4 = hexanoic acid and 
several unidentified peaks. 
TABLE I 
RETENTION TIMES (tx) AND RRT OF THE VOLATILE CARBOXYLIC ACIDS ON THE 
SP-1200 COLUMN (90-200°C TEMPERATURE GRADIENT) 
Organic acid tR (min) RRT 
Propanoic 4.0 0.58 
Isobutyric 6.8 0.81 
Internal standard 6.6- 7.2 1.00 
Butanoic 6.6- 7.2 1.00 
2-Methylbutanoic 8.6 9.2 1.28-1.30 
3-Methylbutanoic 8.6- 9.2 1.28-1.30 
Crotonic 9.0-10.4 1.36-1.39 
Pentanoic 10.2-11.0 1.53-1.65 
,+Methylcrotonic 11.4-12.2 1.69-1.73 
Tiglic 11.8-12.6 1.75-1.79 
Isocaproic 12.6-13.2 1.83-1.91 






Fig. 2. A, Profile of the standard volatile carboxylic acid mixture on the SP-1000 column 
isothermal at 150°C. Peaks: 1 = propanoic and isobutyric acids; 2 = internal standard, 
trimethylacetic acid; 3 = butanoic acid; 4 = 2-methylbutanoic and 3-methylbutanoic acids; 
5 = crotonic acid; 6 = pentanoic acid; 7 = p-methylcrotonic acid; 8 = isocaproic acid; 9 = 
tiglic acid; 10 = hexanoic acid. The concentration of each acid was 3 nmol/ml. B, Profile of 
the standard volatile e-ketocarboxylic acid mixture isothermally (150°C) on the SP-1000 
column. Peaks: 1 = internal standard; 2 = pyruvic acid; 3 = or-ketoisovaleric acid and a-keto- 
butyric acid; 4 = a-ketovaleric acid and a-keto-p-methylvaleric acid; 5 = CY-ketoisocaproic 
acid; 6 = succinic acid; and 7 = lactic acid. The concentration of each acid was 0.4 ~mol/ml. 
Fig. 3. A, Profile of a urine sample from an infant who had methylmalonic aciduria 
(SP-1260 column). Peaks: 1 = propanoic acid (11.0 rmol/ml) from the thermal decarboxyla- 
tion of methylmalonic acid; 2 = internal standard, trimethylacetic acid. B, Profile of a 
Plasma sample from an infant who had methylmalonic aciduria (SP-1200 column). Peaks: 
1 = Propanoic acid (17.4 pmol/ml) from the thermal decarboxylation df methylmalonic 
acid; 2 E internal standard, trimethylacetic acid. Attenuation 16. lo-“. 
carboxylic acids may decompose under these chromatographic conditions, 
thus altering peak identification. Each carboxylic acid, however, did afford a 
single peak with a reproducible relative retention time when analyzed by GC. 
Definitive identification of each peak should be determined by GC-MS. 
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TABLE II 
RETENTION TIMES ( tR) AND RRT OF THE VOLATILE CARBOXYLIC ACIDS ON THE 
SP-1000 COLUMN (ISOTHERMAL AT 160°C) 
Carboxylic acid TV (min) RRT 
Propanoic 2.0-2.2 0.83-0.92 
Isobutyric 7.0-2.2 0.83-0.92 
Internal standard 2.4 1.00 
Butanoic 7.5-3.0 1.25 
2-Methylbutanoic 3.6-3.8 1.50-1.5s 
3-Methylbutanoic 3.6-3.8 1.60-1.58 
Crotonic 4.6-4.8 1.92--2.00 
Pentanoic 5-o-5.4 2.08-2.25 
8-Methylcrotonic 5.8-6.0 2.42-2.50 
Isocaproic 6.4 2.67 
Tiglic 7.2 3.00 
Hexanoic 7.6 3.17 
Pyruvic 4.6-4.8 1.92-2.00 
cY-Ketoisovaleric 8.0 3.08 
e -Ketobutyric 8.0 3.08 
wKeto$-methylvaleric 11.2 4.31 
01 -Ketovaleric 11.2 4.31 
ol-Ketoisocaproic 12.4 4.77 
a-Ketocaproic 17.0 6.54 
Succinic 20.6 7.92 
Lactic 23.4 9.00 
Ghost peaks [ 111 can be a problem on both the SP-1200 and the SP-1000 
columns. We were able to minimize the appearance of ghost peaks in our 
profiles by the injection of 10 ~1 of a 1% formic acid solution onto the column 
at the end of each profile. 
With these procedures, the average column lifetime is 6 months for the 
SP-1200 column and 8-12 months for the SP-1000 column. Over the course 
of daily use, the retention time of the volatile acids on the SP-1200 column 
steadily decreases over the 6-months lifetime of the column. For example, the 
retention time for the internal standard on a new column was 6.6 min, after 
3 months of use the internal standard retention time was 5.4 min and after 
5 months the retention time was 4.0 min. The resolution of the volatile acids 
was not changed over the column lifetime. There is a similar but less rapid 
change in the volatile acid retention times over the lifetime of the SP-1000 
column. 
We have found that this profiling procedure permits the rapid identification 
of abnormal volatile fatty acid concentrations in the plasma and urine of ill 
newborns suspected of having inborn errors of metabolism. Recently this 
method permitted positive identification of methylmelonic aciduria in an 
infant only 30 min after the sample was received in the laboratory. Since 
early institution of therapy is crucial for a favorable outcome in these circum- 
stances, we recommend this method for early identification of the volatile 
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